Sign in

NCT01179815Recruiting

Swiss Diabetes Registry - SwissDiab Study

Swiss Diabetes Registry - SwissDiab Study, a Prospective Cohort Study of Patients With Diabetes in Switzerland

Source: ClinicalTrials.gov · Last updated 11 Jun 2026

Brief summary (registry, in English)

Currently, the estimated number of people with diabetes mellitus is approximately 387 million people worldwide. Due to population growth, urbanization, ageing and the rising prevalence of obesity the numbers of individuals with diabetes is increasing likewise. It has been shown that improving glycemic control is associated with a reduction in late complications of diabetes, such as cardiovascular and microvascular diseases. Therefore, treatment guidelines were established internationally by large and renowned associations and adopted by many countries. For Switzerland only sparse data exist on the actual implementation of such recommendations and on patient's well-being. The Swiss Diabetes Registry - SwissDiab Study is a prospective cohort study aiming at including and collecting data of virtually all patients regularly seen and treated at the study centers (≈ 500 patients each), irrespective of type, duration of diabetes or treatment . This allows the evaluation of diabetes treatment strategies at these centers. Furthermore, risk indicators for micro- and macrovascular complications, mortality as well as costs and quality of life will be assessed. Data will be recorded through an internet-based, electronic database specifically designed for this study. At a later perspective it is planned to extend data collection to general practitioner/family doctor networks in order to include a larger and more representative sample of patients with diabetes in Switzerland.

Status (registry)
Recruiting
Study type
Observational
Enrollment
1500 (estimated)
First submitted
10 Aug 2010
Start date
Jan 2010
Primary completion date
Jan 2099
Lead sponsor
Insel Gruppe AG, University Hospital Bern
NCT number
NCT01179815

What you commit to

  • Study type: Observational
  • Planned participants: 1500
  • From Jan 2010 to the primary completion date, Jan 2099
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with gestational diabetes mellitus, patients unable to give informed consent, legally incompetent or incapable to comply with the study terms and conditions as well as patients with significantly reduced life expectancy (\<1 year) will be excluded

Who the study is looking for

  • Age \> 18 years
  • Diagnosis of diabetes mellitus according to ADA criteria
  • Informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung, Inselspital Bern
Coordinator of this site? Confirm its status
BernSwitzerlandRecruiting
Service d'endocrinologie, diabétologie et métabolisme
Coordinator of this site? Confirm its status
LausanneSwitzerlandRecruiting
Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen, Kantonsspital St.Gallen
Coordinator of this site? Confirm its status
Sankt GallenSwitzerlandRecruiting
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich
Coordinator of this site? Confirm its status
ZurichSwitzerlandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.